172 related articles for article (PubMed ID: 21786443)
1. Prognostic implications of the NIH consensus criteria in children with chronic graft-versus-host disease.
Lee JW; Lee DH; Jang PS; Yi MS; Chung NG; Cho B; Jeong DC; Kim HK
Yonsei Med J; 2011 Sep; 52(5):779-86. PubMed ID: 21786443
[TBL] [Abstract][Full Text] [Related]
2. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
3. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
Cuvelier GDE; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; West LJ; Pan B; Al Hamarneh YN; Halevy A; Schultz KR
Blood; 2019 Jul; 134(3):304-316. PubMed ID: 31043425
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.
Vigorito AC; Campregher PV; Storer BE; Carpenter PA; Moravec CK; Kiem HP; Fero ML; Warren EH; Lee SJ; Appelbaum FR; Martin PJ; Flowers ME;
Blood; 2009 Jul; 114(3):702-8. PubMed ID: 19470693
[TBL] [Abstract][Full Text] [Related]
5. Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease.
Aisa Y; Mori T; Kato J; Yamane A; Kohashi S; Kikuchi T; Okamoto S
Int J Hematol; 2013 Feb; 97(2):263-71. PubMed ID: 23371545
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of NIH consensus criteria for chronic graft-versus-host disease.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim DW; Lee JW; Min WS; Kim CC
Leukemia; 2009 Jan; 23(1):78-84. PubMed ID: 18830253
[TBL] [Abstract][Full Text] [Related]
7. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.
Weisdorf D; Haake R; Blazar B; Miller W; McGlave P; Ramsay N; Kersey J; Filipovich A
Blood; 1990 Feb; 75(4):1024-30. PubMed ID: 2302454
[TBL] [Abstract][Full Text] [Related]
8. Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients.
Inamoto Y; White J; Ito R; Martin PJ; Fatobene G; Ito A; Tanaka T; Kurosawa S; Kim SW; Bar M; Sorror ML; Sandmaier BM; Lee SJ; Fukuda T; Flowers MED
Blood Adv; 2019 Sep; 3(18):2764-2777. PubMed ID: 31551243
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
Flowers ME; Inamoto Y; Carpenter PA; Lee SJ; Kiem HP; Petersdorf EW; Pereira SE; Nash RA; Mielcarek M; Fero ML; Warren EH; Sanders JE; Storb RF; Appelbaum FR; Storer BE; Martin PJ
Blood; 2011 Mar; 117(11):3214-9. PubMed ID: 21263156
[TBL] [Abstract][Full Text] [Related]
10. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
[TBL] [Abstract][Full Text] [Related]
11. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
[TBL] [Abstract][Full Text] [Related]
12. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Flowers ME; Parker PM; Johnston LJ; Matos AV; Storer B; Bensinger WI; Storb R; Appelbaum FR; Forman SJ; Blume KG; Martin PJ
Blood; 2002 Jul; 100(2):415-9. PubMed ID: 12091330
[TBL] [Abstract][Full Text] [Related]
13. Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class I and II beta thalassemia major.
Ghavamzadeh A; Iravani M; Ashouri A; Mousavi SA; Mahdavi N; Shamshiri A; Hadjibabaie M; Namdar R; Nedaeifard L; Ghaffari H; Alimoghaddam K
Biol Blood Marrow Transplant; 2008 Mar; 14(3):301-8. PubMed ID: 18275896
[TBL] [Abstract][Full Text] [Related]
14. Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria.
Jagasia M; Giglia J; Chinratanalab W; Dixon S; Chen H; Frangoul H; Engelhardt B; Goodman S; Greer J; Kassim A; Morgan D; Ruffner K; Schuening F
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1207-15. PubMed ID: 17889358
[TBL] [Abstract][Full Text] [Related]
15. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.
Cutler C; Giri S; Jeyapalan S; Paniagua D; Viswanathan A; Antin JH
J Clin Oncol; 2001 Aug; 19(16):3685-91. PubMed ID: 11504750
[TBL] [Abstract][Full Text] [Related]
17. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.
Filipovich AH; Weisdorf D; Pavletic S; Socie G; Wingard JR; Lee SJ; Martin P; Chien J; Przepiorka D; Couriel D; Cowen EW; Dinndorf P; Farrell A; Hartzman R; Henslee-Downey J; Jacobsohn D; McDonald G; Mittleman B; Rizzo JD; Robinson M; Schubert M; Schultz K; Shulman H; Turner M; Vogelsang G; Flowers ME
Biol Blood Marrow Transplant; 2005 Dec; 11(12):945-56. PubMed ID: 16338616
[TBL] [Abstract][Full Text] [Related]
18. [Study on graft-versus-host disease in the allogeneic peripheral blood stem cell transplantation for the treatment of leukemia].
Zhang WP; Wang JM; Ju XP; Song XM; Tong SP; Li HM
Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):129-33. PubMed ID: 12697123
[TBL] [Abstract][Full Text] [Related]
19. Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation.
Scholl S; Sayer HG; Mügge LO; Kasper C; Pietraszczyk M; Kliche KO; Clement JH; Höffken K
J Cancer Res Clin Oncol; 2004 Dec; 130(12):704-10. PubMed ID: 15365821
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy.
Pérez-Simón JA; Encinas C; Silva F; Arcos MJ; Díez-Campelo M; Sánchez-Guijo FM; Colado E; Martín J; Vazquez L; Del Cañizo C; Caballero D; San Miguel J
Biol Blood Marrow Transplant; 2008 Oct; 14(10):1163-1171. PubMed ID: 18804047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
